Form 4: Sangamo Therapeutics VP Amy Pooler Reports Stock Transactions for Tax Withholding
SEC Form 4 Filing
Amy Pooler, VP at Sangamo Therapeutics, reports disposition of shares to cover tax obligations related to RSU vesting, with no discretionary trading involved.
Summary
- On August 24 and 25, 2024, Amy Pooler, VP at Sangamo Therapeutics, disposed of shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
- The shares were surrendered to the issuer at a price of $0.86 per share.
- On August 24, 703 shares were disposed of for tax withholding.
- On August 25, 493 shares were disposed of for tax withholding.
- Following these transactions, Pooler beneficially owns 193,923 shares of Sangamo Therapeutics common stock.
- The RSU grants are subject to continuous service and may be accelerated as provided in the 2018 Equity Incentive Plan.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 02/25/2022 | Date of RSU grant that will vest in successive equal quarterly installments through February 25, 2025 |
| 02/24/2023 | Date of RSU grant that will vest in successive equal quarterly installments through February 24, 2026 |
| 01/22/2024 | Date of RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter. |
| 08/23/2024 | Issuer's closing stock price of $0.86/share used for tax withholding purposes. |
| 08/24/2024 | Date of first transaction: Disposition of 703 shares for tax withholding. |
| 08/25/2024 | Date of second transaction: Disposition of 493 shares for tax withholding. |
| 08/27/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.